Establishment of a human iPSC (ZZUNEUi026-A) from a dilated cardiomyopathy patient carrying heterozygous Vinculin (c. 625A > T) mutant

Establishment of a human iPSC (ZZUNEUi026-A) from a dilated cardiomyopathy patient carrying heterozygous Vinculin (c. 625A > T) mutant

Dilated cardiomyopathy (DCM) is defined by left ventricular (or biventricular dilation) and systolic dysfunction, which eventually develops into congestive heart failure and arrhythmia. Vinculin is a membrane-associated protein, which functions to transmit contractile force. Defects in vinculin have...

Full description

Bibliographic Details
Main Authors:	Yangyang Liu, Xiaowei Li, Xiaoyan Zhao, Jianzeng Dong, Chunyang Zhang, Tao Lin
Format:	Article
Language:	English
Published:	Elsevier 2022-07-01
Series:	Stem Cell Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1873506122001611

Similar Items

An integration-free iPSC line ZZUNEUi028-A derived from a patient with hypertrophic cardiomyopathy carrying a heterozygous mutation (c. 1504 C > T) in MYBPC3 gene
by: Dong Cheng, et al.
Published: (2022-08-01)

Induced pluripotent stem cell (iPSC) line (ZZUNEUi009-A) from a healthy female individual
by: Mengduan Liu, et al.
Published: (2021-05-01)

Generation of a hiPSC line ZZUNEUi017-A from a patient with dilated cardiomyopathy caused by mutation in TTN
by: Shujian Huang, et al.
Published: (2021-04-01)

Generation of an iPSC line (ZZUNEUi016-A) derived from a hypertrophic cardiomyopathy patient with the heterozygote mutation in MYH7 gene
by: Guangli Guo, et al.
Published: (2021-05-01)

Generation of a human iPSC line ZZUNEUi015-A from a patient with hypertrophic cardiomyopathy caused by mutation in ALPK3
by: Xiaoxu Tian, et al.
Published: (2021-04-01)

A heterozygous TTN (c. 79,684C>T) mutant human induced pluripotent stem cell line (ZZUNEUi023-A) generated from a Kazakh patient with dilated cardiomyopathy
by: Xiaowei Li, et al.
Published: (2021-12-01)

Generation of a heterozygous FLNC mutation-carrying human iPSC line, USFi002-A, for modeling dilated cardiomyopathy
by: Mariana A. Argenziano, et al.
Published: (2021-05-01)

An integration-free iPSC line ZZUNEUi008-A derived from dermal fibroblasts of a child with cardiac valvular dysplasia carrying a mutation in FLNA gene
by: Xiaowei Li, et al.
Published: (2020-08-01)

Generation of a human iPSC line ZZUNEUi014-A from a patient with antithrombin deficiency caused by mutation in SERPINC1 gene
by: Jin Hong, et al.
Published: (2022-03-01)

Generation of a hiPSC line ZZUNEUi012-A from a healthy female individual
by: Mengyu Wang, et al.
Published: (2021-01-01)

Generation of a hiPSC line ZZUNEUi007-A from a patient with hypertrophic cardiomyopathy caused by mutation in MYH7
by: Xiaowei Li, et al.
Published: (2020-03-01)

An integration-free iPSC line ZZUNEUi029-A derived from peripheral blood mononuclear cells of a patient with familial hypercholesterolemia carrying a mutation in LDLR gene
by: Kui Zhu, et al.
Published: (2023-09-01)

Generation of a human induced pluripotent stem cell line ZZUNEUi030-A from a female patient carrying a heterozygous CALM2 (c.395 A > T) mutation
by: Chongpei Hua, et al.
Published: (2024-12-01)

TAB2 deficiency induces dilated cardiomyopathy by promoting mitochondrial calcium overload in human iPSC-derived cardiomyocytes
by: Wenrui Sun, et al.
Published: (2025-02-01)

A heterozygous MYBPC3 (c. 772+1G > A) mutant human induced pluripotent stem cell line (ZZUNEUi025-A) generated from a male patient with hypertrophic cardiomyopathy
by: Xi Zhao, et al.
Published: (2022-04-01)

Generation of an iPSC cell line (USFi003-A) from a patient with dilated cardiomyopathy carrying a heterozygous mutation in LMNA (p.R541C)
by: Jiajia Yang, et al.
Published: (2021-07-01)

A heterozygous MYH7 (c. 2156G > A) mutant human induced pluripotent stem cell line (ZZUNEUi020-A) generated from a patient with hypertrophic cardiomyopathy
by: Xiaowei Li, et al.
Published: (2021-03-01)

Generation of three iPSC lines from dilated cardiomyopathy patients carrying a pathogenic LMNA variant
by: Chelsea Lee, et al.
Published: (2022-03-01)

Heterozygous LMNA mutation-carrying iPSC lines from three cardiac laminopathy patients
by: Sangkyun Cho, et al.
Published: (2022-03-01)

Generation of an integration-free induced pluripotent stem cell (iPSC) line (ZZUNEUi001-A) from a healthy male individual
by: Jiwei Zhang, et al.
Published: (2020-05-01)

Human induced pluripotent stem cell line ZZUNEUi027-A generated from a long QT syndrome patient with a heterozygous KCNH2 (c. 128 A > G) mutant
by: Jiangtao Zhao, et al.
Published: (2022-08-01)

Generation of two heterozygous MYBPC3 mutation-carrying human iPSC lines, SCVIi001-A and SCVIi002-A, for modeling hypertrophic cardiomyopathy
by: Lichao Liu, et al.
Published: (2021-05-01)

Generation of two iPSC lines from Mowat-Wilson syndrome patients carrying heterozygous ZEB2 mutations
by: Giulia Gorrieri, et al.
Published: (2024-04-01)

Production of CSSi013-A (9360) iPSC line from an asymptomatic subject carrying an heterozygous mutation in TDP-43 protein
by: Angela D'Anzi, et al.
Published: (2022-08-01)

An induced pluripotent stem cells line (ZZUNEUi022-A) derived from urine cells of healthy male human
by: Yangyang Liu, et al.
Published: (2021-03-01)

Generation and characterization of two iPSC lines carrying heterozygous or homozygous nonsense mutation in PROM1 gene from a single family
by: Ping Xu, et al.
Published: (2022-10-01)

Generation of iPSC lines from CPVT patient carrying heterozygous mutation p.A2254V in the ryanodine receptor 2 gene
by: Wener Li, et al.
Published: (2021-05-01)

Establishment of an arrhythmogenic right ventricular cardiomyopathy derived iPSC cell line (USFi004-A) carrying a heterozygous mutation in PKP2 (c.1799delA)
by: Jiajia Yang, et al.
Published: (2021-07-01)

Generation of the iPSC line FINi002-A from a male Parkinson's disease patient carrying compound heterozygous mutations in the PRKN gene
by: C. Pavan, et al.
Published: (2023-12-01)

Generation of an IPSC line from a patient with hypertrophic cardiomyopathy carrying a mutation in MYH6 gene
by: Lu Wang, et al.
Published: (2021-01-01)

Generation of iPSC line NCHi015-A from a patient with truncus arteriosus carrying heterozygous variants in KMT2D and NOTCH1
by: Jerry Wang, et al.
Published: (2024-08-01)

Establishment of a novel human iPSC line (YCMi003-A) from a patient with dilated cardiomyopathy carrying genetic variant LMNA p.Asp364His
by: Jaewon Oh, et al.
Published: (2021-10-01)

Generation of CRISPR/Cas9-edited human iPSC lines carrying homozygous and heterozygous SAMD9 p.I983S mutations
by: Majd Khiami, et al.
Published: (2024-12-01)

Establishment of NCHi009-A, an iPSC line from a patient with hypoplastic left heart syndrome (HLHS) carrying a heterozygous NOTCH1 mutation
by: Subhodip Adhicary, et al.
Published: (2023-02-01)

Establishment of an iPSC line (CPGHi005-A) from a patient with Waardenburg syndrome carrying a heterozygous SVA-F retrotransposon insertion into SOX10
by: Xiaohong Li, et al.
Published: (2022-07-01)

Lamin A/C deficiency-mediated ROS elevation contributes to pathogenic phenotypes of dilated cardiomyopathy in iPSC model
by: Hangyuan Qiu, et al.
Published: (2024-08-01)

Generation of two iPSC lines from dilated cardiomyopathy patients with pathogenic variants in the SCN5A gene
by: Ryan Dexheimer, et al.
Published: (2024-10-01)

Establishment of a human iPSC line (SDQLCHi010-A) from a patient with optic nerve malformation carrying a heterozygous mutation in PAX6 gene
by: Haiyan Zhang, et al.
Published: (2019-12-01)

Establishment of an iPSC line from a NDD patient with a heterozygous mutation in the CTNNB1 gene
by: Jiaying Ning, et al.
Published: (2024-09-01)

Generation of heterozygous SAMD9 CRISPR/Cas9-edited iPSC line (ESi086-A-3), carrying p.I1567M mutation
by: Joan Pera, et al.
Published: (2022-10-01)